173 related articles for article (PubMed ID: 26239537)
1. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
[TBL] [Abstract][Full Text] [Related]
2. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.
Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D
Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743
[TBL] [Abstract][Full Text] [Related]
3. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
[TBL] [Abstract][Full Text] [Related]
4. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
[TBL] [Abstract][Full Text] [Related]
5.
Riedl S; Rinner B; Schaider H; Liegl-Atzwanger B; Meditz K; Preishuber-Pflügl J; Grissenberger S; Lohner K; Zweytick D
Oncotarget; 2017 Sep; 8(42):71817-71832. PubMed ID: 29069749
[TBL] [Abstract][Full Text] [Related]
6. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
[TBL] [Abstract][Full Text] [Related]
7. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
[TBL] [Abstract][Full Text] [Related]
8. Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides.
Silva T; Adão R; Nazmi K; Bolscher JG; Funari SS; Uhríková D; Bastos M
Biochim Biophys Acta; 2013 May; 1828(5):1329-39. PubMed ID: 23384417
[TBL] [Abstract][Full Text] [Related]
9. A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60).
Onishi J; Roy MK; Juneja LR; Watanabe Y; Tamai Y
J Pept Sci; 2008 Sep; 14(9):1032-8. PubMed ID: 18425992
[TBL] [Abstract][Full Text] [Related]
10. Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.
Desai TJ; Toombs JE; Minna JD; Brekken RA; Udugamasooriya DG
Oncotarget; 2016 May; 7(21):30678-90. PubMed ID: 27120792
[TBL] [Abstract][Full Text] [Related]
11. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
12. PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells.
Lu Y; Zhang TF; Shi Y; Zhou HW; Chen Q; Wei BY; Wang X; Yang TX; Chinn YE; Kang J; Fu CY
Sci Rep; 2016 Feb; 6():20823. PubMed ID: 26860588
[TBL] [Abstract][Full Text] [Related]
13. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
Wilms D; Andrä J
J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
[TBL] [Abstract][Full Text] [Related]
14. Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface.
Iwasaki T; Ishibashi J; Tanaka H; Sato M; Asaoka A; Taylor D; Yamakawa M
Peptides; 2009 Apr; 30(4):660-8. PubMed ID: 19154767
[TBL] [Abstract][Full Text] [Related]
15. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
[TBL] [Abstract][Full Text] [Related]
16. Structure of the N-terminal segment of human retinol dehydrogenase 11 and its preferential lipid binding using model membranes.
Lhor M; Méthot M; Horchani H; Salesse C
Biochim Biophys Acta; 2015 Mar; 1848(3):878-85. PubMed ID: 25542782
[TBL] [Abstract][Full Text] [Related]
17. Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.
Zweytick D; Deutsch G; Andrä J; Blondelle SE; Vollmer E; Jerala R; Lohner K
J Biol Chem; 2011 Jun; 286(24):21266-76. PubMed ID: 21515687
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine lipids and membrane order precisely regulate the activity of Polybia-MP1 peptide.
Alvares DS; Ruggiero Neto J; Ambroggio EE
Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1067-1074. PubMed ID: 28274844
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
